Roundtable Participants 4150
November 1, 2006
BUSINESS PLANNING & TECHNOLOGY DEVELOPMENT
Alexander K. Arrow, MD, is a medical technology analyst with Lazard Capital Markets (New York City).
Richard S. Cohen is president of the Walden Group Inc. (Tarrytown, NY), a strategic investment-banking firm specializing in the healthcare industry.
Thomas J. Gunderson is a managing director and senior research analyst at Piper Jaffray & Co. (Minneapolis), where he follows cardiology and other medical device companies.
Manfred Scholz, PhD, is president of Scholz Consulting Partners (Medford, MA), a strategic planning and business development consultancy for diagnostics and life sciences firms.
John J. Viscogliosi is a principal in the investment banking firm of Viscogliosi Bros. LLC (New York City), and is chairman and CEO of Raymedica Inc. (Minneapolis), a medical device company focused on the development and manufacture of spinal disk nucleus arthroplasty devices to treat degenerative disk disease and disk herniations, and developer of the first prosthetic disk nucleus device.
Copyright ©2006 MX
You May Also Like